Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and …
!["Beckman Coulter Fujirebio Neurodegenerative Assays"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/Beckman_Coulter_Diagnostics_2.jpg?resize=600%2C427&ssl=1)
!["Beckman Coulter Fujirebio Neurodegenerative Assays"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/Beckman_Coulter_Diagnostics_2.jpg?resize=600%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and …
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced it …
Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for …